Prognostic risk factors in 113 patients undergoing cephalic duodenopancreatectomy for distal cholangiocarcinoma
Gastroenterol Hepatol. 2024 May;47(5):448-456.
doi: 10.1016/j.gastrohep.2023.09.009.
Epub 2023 Oct 10.
[Article in
English,
Spanish]
Authors
Juli Busquets
1
, Luís Secanella
2
, Paula Cifre
3
, María Sorribas
4
, Teresa Serrano
5
, Laura Martínez-Carnicero
6
, David Leiva
6
, Berta Laquente
7
, Silvia Salord
8
, Nuria Peláez
4
, Juan Fabregat
4
Affiliations
- 1 Unitat de Cirurgia Hepatobiliopancreàtica, Servei de Cirurgia General i Digestiva, Hospital Universitari de Bellvitge, Barcelona, España; Departament de Ciències Clíniques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, España; Research Group of Hepato-biliary and Pancreatic Diseases, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, España. Electronic address: jbusquets@bellvitgehospital.cat.
- 2 Unitat de Cirurgia Hepatobiliopancreàtica, Servei de Cirurgia General i Digestiva, Hospital Universitari de Bellvitge, Barcelona, España; Research Group of Hepato-biliary and Pancreatic Diseases, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; Departament d'Infermeria Fonamental i Medicoquirúrgica, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, España.
- 3 Unitat de Cirurgia Hepatobiliopancreàtica, Servei de Cirurgia General i Digestiva, Hospital Universitari de Bellvitge, Barcelona, España; Departament de Ciències Clíniques, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, España.
- 4 Unitat de Cirurgia Hepatobiliopancreàtica, Servei de Cirurgia General i Digestiva, Hospital Universitari de Bellvitge, Barcelona, España; Research Group of Hepato-biliary and Pancreatic Diseases, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, España.
- 5 Servei de Anatomia Patològica, Hospital Universitari de Bellvitge, Barcelona, España.
- 6 Servei de Radiodiagnòstic, Hospital Universitari de Bellvitge, Barcelona, Spain.
- 7 Servei d'Oncologia Mèdica, Instituto Catalán de Oncología. Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, España.
- 8 Research Group of Hepato-biliary and Pancreatic Diseases, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; Servei de Gastroenterologia, Hospital Universitari de Bellvitge, Barcelona, España.
Abstract
Introduction:
Distal cholangiocarcinoma is a malignant epithelial neoplasia that affects the extrahepatic bile ducts, below the cystic duct. No relevant relationship between perioperative factors and worse long-term outcome has been proved.
Objective:
To analyze the risk factors for mortality and long-term recurrence of distal cholangiocarcinoma in resected patients.
Materials and methods:
A single-center prospective database of patients operated on for distal cholangiocarcinoma between 1990 and 2021 was analyzed in order to investigate mortality and recurrence factors.
Results:
One hundred and thirteen patients have undergone surgery, with mean actuarial survival of 100.2 (76-124) months after resection. The bivariate study did not show differences between patients depending on age or preoperative variables studied. When multivariate analysis was performed, the presence of affected adenopathy was a risk factor for long-term mortality. The presence of affected lymph nodes, tumor recurrence, and biliary fistula during the postoperative period implied worse actuarial survival when comparing the Kaplan-Meier curves.
Conclusions:
The presence of affected lymph nodes influence the prognosis of the disease. The occurrence of biliary fistula during postoperative cholangiocarcinoma distal could aggravate long-term outcomes, a finding that should be reaffirmed in future studies.
Keywords:
Cholangiocarcinoma; Colangiocarcinoma; Duodenopancreatectomía cefálica; Factores de riesgo; Pancreatoduodenectomy; Postoperative risk factors; Postoperative survival; Supervivencia a largo plazo.
Copyright © 2023 Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Bile Duct Neoplasms* / surgery
-
Cholangiocarcinoma* / surgery
-
Female
-
Humans
-
Male
-
Middle Aged
-
Neoplasm Recurrence, Local / epidemiology
-
Pancreaticoduodenectomy* / adverse effects
-
Prognosis
-
Prospective Studies
-
Retrospective Studies
-
Risk Factors
-
Survival Rate